1 August 2026 in Journal of Clinical and Analytical Medicine
Advances in ischemic stroke diagnosis and treatment are pivotal in reducing its impact worldwide. This study examines ischemic stroke patient management and outcomes in Morocco. A narrative review analyzed ischemic stroke management and outcomes in Moroccan hospitals. From 28 studies, patients typically arrived at imaging departments 26 to 61 hours after symptom onset. Treatment focused on cardiovascular risk factors: Antihypertensives (43% to 67.8%), platelet aggregation inhibitors (16% to 57%), statins (10% to 12%), antidiabetics (13.2% to 47.9%), and thrombolysis (1.94% to 14.7%). Carotid stenosis and hemicraniectomy were less common. National Institutes of Health Stroke Scale scores (NIHSS) improved post-thrombolysis from 10.4-14.8 initially to 9.56 within 24 hours. Modified Rankin scores varied widely, from full recovery (29.65%) to recurrence (14.75%). Acute phase mortality ranged from 1.1% to 16.4%, with 3-month mortality from 4.3% to 32.5%. Improving stroke care in Morocco entails reducing pre-hospital thrombolysis delays and expanding neurovascular units nationwide.
1 July 2026 in Journal of Clinical and Analytical Medicine
Aim This study aims to assess lipid and glucose metabolism in elderly ischemic stroke patients in Morocco, highlighting the prevalence of metabolic disturbances as key risk factors. Given the strong link between aging and stroke, understanding metabolic profiles may improve prevention and management strategies. Methods A retrospective analysis included 213 patients aged ≥60 years hospitalized for ischemic stroke between January 1 and December 31, 2024. Lipid profile, fasting blood glucose, and HbA1c were measured within 24 hours of admission using enzymatic colorimetric assays and UV/Visible spectrophotometry (500 nm ± 20). Data were analyzed using JAMOVI software (v2.21). Results Mean age was 75.31 ± 9.43 years. Metabolic disorders were highly prevalent: 25% had glucose metabolism abnormalities, including 18% with diabetes (HbA1c >6.5%). Dyslipidemia affected 60% of patients, with 82.6% exhibiting elevated LDL (>1.6 g/L), 80.5% low HDL (2, indicating high cardiovascular risk. Conclusion The high prevalence of dyslipidemia and glycemic disorders underscores their critical role in ischemic stroke among the elderly. These findings confirm strong associations between metabolic syndrome, type 2 diabetes, and stroke risk. Early detection and strict control of lipid and glucose metabolism are essential to reduce neurovascular recurrence. Integrated metabolic screening should be part of routine stroke care in older adults, particularly in populations with limited preventive health strategies. Improving metabolic management could significantly impact stroke outcomes in this vulnerable group.